Description
16,23-Oxidoalisol B, a naturally occurring compound, exhibits remarkable potential as an antitumor agent. Its efficacy in impeding the progression of melanoma, colon cancer, and breast cancer cells has been identified and validated through several investigations. The compound's potential rests on its unique ability to trigger cell cycle arrest and apoptosis in cancerous cells - properties that make it an excellent target for developing novel cancer therapies.